Last checked at LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec
LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec
22 Jan 21 09:32
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Vectura Share News (VEC)
VEC Share
Price
VEC Share
News
VEC Share
Chat
VEC Share
Trades246
VEC
Live RNS
VEC Share
Charts
VEC Level 2
Console
VEC Live
Share Price
VEC Broker
Ratings
VEC Directors
Deals
VEC Financial
Diary
VEC
Fundamentals
VEC Short
Positions
VEC
Media
VEC Information
Share Price Information for Vectura (VEC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
112.60
Bid:
112.40
Ask:
113.00
Change:
1.20
(1.08%)
Spread:
0.60 (0.53%)
Open:
113.80
High:
113.80
Low:
111.00
Yest. Close:
111.40
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.22 Jan 21 09:32Vectura Forecasts 2020 Earnings To Top Board Expectations
Vectura Forecasts 2020 Earnings To Top Board Expectations
12 Jan 21 10:13Vectura reports 'strong' operational performance in 2020
(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.
12 Jan 21 08:16UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle
UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle
30 Dec 20 19:10Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation
Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation
29 Dec 20 12:04Glaxo not seeking re-hearing in Ellipta litigation, says Vectura
(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.
29 Dec 20 10:04LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal
LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal
18 Dec 20 17:08LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound
LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound
18 Dec 20 12:08UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
18 Dec 20 10:45Hikma rallies as it launches generic version of Glaxo asthma treatment
(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.
18 Dec 20 08:12Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus
17 Dec 20 18:10IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board
IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board
4 Dec 20 13:05Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug
Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug
30 Nov 20 09:53Vectura signs asthma treatment deal with Kinaset
(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.
30 Nov 20 08:06Court denies GSK appeal in Vectura intellectual property dispute
(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.
20 Nov 20 08:34